CMTP in the News
CMTP Receives Funding Award for Project on Clinician Engagement in Research
September 27, 2016A team at CMTP has been approved for a $250,000 funding award through the Eugene Washington PCORI Engagement Awards program, an initiative of the Patient-Centered Outcomes Research Institute (PCORI). The funds will support the development of better strategies for partnering with practicing clinicians to conduct comparative effectiveness research (CER) and patient-…
GPC to Host Forum on Payer Policies for Liquid Biopsy & Emerging Clinical Genomics
August 1, 2016The Green Park Collaborative (GPC) will host a Genomics Technology Policy Forum November 2 and 3 in Baltimore, Maryland. The two-day forum will foster in-depth discussions on evidence, utility, and value between innovators, payers, and other key stakeholders shaping the future of genomics for patient care.
Maryland Commerce Convenes Partners to Form Centers of Excellence in Biomanufacturing, Transformative Medicine
June 8, 2016Johns Hopkins University, University of Maryland, Baltimore and University of Maryland, College Park to collaborate with state on commercialization of transformative medicines, devices
Study Seeks Women’s Insights on What Works Best for Uterine Fibroids
May 9, 2016Duke University has announced the launch of a new registry that will enroll over 10,000 women with uterine fibroids and will evaluate the efficacy and outcomes of various treatments and medications. The Center for Medical Technology Policy (CMTP) has played an integral role in this effort, managing the Stakeholder Advisory Group …
GPC Genomic Databases Initiative Addresses Recommendations of Academy’s Biomarkers Report
March 4, 2016A new report from the National Academies of Sciences, Engineering, and Medicine aims to reduce key barriers to the development and clinical adoption of biomarker tests for molecularly targeted therapies. Included in the report are recommendations designed to facilitate rapid learning from patient experience through enhanced data-collection and data-sharing in…
CMTP Issues Recommendations for Late Phase Drug Studies in Type 2 Diabetes
July 2, 2014CMTP has issued an Effectiveness Guidance Document (EGD) for Recommendations for Late Phase Drug Studies in Type 2 Diabetes. The EGD provides guidance for improving the design, conduct, and reporting of late phase (approval and post-approval) drug studies for patients with type 2 diabetes.
Sean Tunis Testifies for House Subcommittee Hearing on "21st Century Cures: The PCAST Report on Drug Innovation"
May 20, 2014Sean Tunis provided testimony to the US House of Representatives Energy and Commerce Subcommittee on Health Hearing on 21st Century Cures: The President's Council of Advisors on Science and Technology (PCAST) Report on Drug Innovation."
CMTP to Develop Guidelines for Clinical Utility Evidence for NGS-based Cancer Tests
January 29, 2014
GPC to Develop Evidence Standards for Next Generation Sequencing-Based Testing in Oncology
January 13, 2014The Green Park Collaborative (GPC-USA), sponsored by the Center for Medical Technology Policy (CMTP), today launched a new effort to develop methodological guidance on the kinds of evidence needed to evaluate promising tests in the rapidly developing field of Next Generation Sequencing (NGS) for cancer diagnosis and treatment.
New Consortia in Oncology and Metabolic Diseases Launch Efforts to Develop Methodological Standards to Guide Reimbursement Decisions
November 21, 2013Green Park Collaborative-USA’s inaugural annual meeting gathers nearly 100 health care leaders from industry, patient groups, payers, regulators and academia.
Quintiles Receives PCORI Funding Award for Comparing Effectiveness of Uterine Fibroid Treatments in Real-World Practice
June 4, 2013The Patient-Centered Outcomes Research Institute (PCORI) awards research funding to Quintiles to compare UFT treatments in real world practice. The study will be supported by CMTP, and is designed to help patients and their clinicians make better informed treatment decisions.